samedan logo
 
 
 
spacer
home > pmps > autumn 2008 > rubber stoppers: delivering safe sterile components
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Rubber Stoppers: Delivering Safe Sterile Components

Supplying ‘ready-to-use’ primary packaging components is the logical follow-up to supplying ‘ready-to-sterilise’ components. By transferring washing and sterilisation operations to the supplier, this concept gives greater flexibility to pharmaceutical laboratories. Delegating a key operation like sterilisation requires the highest degree of quality assurance, and it is the responsibility of the supplier to guarantee the sterility of the parts it supplies. Obtaining sterile components requires mastery of all the applicable pharmaceutical requirements, control over the process before irradiation, and a validation procedure to ensure effective sterilisation.

MASTERY OF THE PRODUCTION PROCESS BEFORE IRRADIATION

Sterile, ‘ready-to-use’ products, whether stoppers or plungers, undergo a specific manufacturing process before being sterilised by gamma radiation...

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer

Print this page
Send to a friend
Privacy statement
News and Press Releases

Leading pharma packaging companies commit to supply for Covid-19 fight

The CEOs of Gerresheimer, Stevanato Group, and SCHOTT are committed to ensuring ample supply of pharmaceutical containers for any Covid-19 vaccine and treatment that is developed, and that no patient shall be left behind, no matter what region of the world they live in.
More info >>

White Papers

Customising the Cold Chain

World Courier

Of all the statistics emerging around the global pharmaceutical industry this year, two big numbers capture the attention of both manufacturers and their logistics partners: $248 billion, the amount the “BRIC” nations (Brazil, Russia, India and China) are poised to account for in pharmaceutical sales for by 2016; and $8 billion, the amount global pharma will spend on cold chain logistics in 2014. Why are these two numbers so noteworthy? They demonstrate that as R&D goes, so goes logistics. As products evolve to meet demands for more targeted therapies, demand for more targeted logistics solutions grows as well. And that means a need for customization for everything from clinical trial samples to finished product.
More info >>

 
Industry Events

World Vaccine Congress Europe

18-21 October 2020, Barcelona, Spain

The World Vaccine Congress is an award-winning series of conferences and exhibitions that have grown to become the largest and most established vaccine meeting of its kind across the globe. Our credibility is show through the prestigious scientific advisory board that spend months of hard work creating a new and topical agenda, year on year.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement